Characteristics of menstruation in women infected with human immunodeficiency virus

OBJECTIVE: To determine the characteristics of menstruation in women infected with human immunodeficiency virus (HIV) and the impact of immunosuppression on menstruation in HIV-infected women. METHODS: In this cross-sectional study, 197 HIV-infected and 189 HIV-uninfected women were interviewed about menstruation and abnormal vaginal bleeding during the previous 12 months. Information was also obtained about CD4+ T-lymphocyte levels of HIV-infected women and other factors, including drug use and weight loss, that might affect menstruation. RESULTS: The number and duration of menses in HIV-infected women were not significantly different from those of uninfected women. During a 12-month period, 154 (78%) of 197 HIV-infected women and 150 (80%) of 188 uninfected women had 10-14 menses (P = .74). The proportions of women in the two groups with intermenstrual bleeding, postcoital bleeding, or no bleeding were also similar. In HIV-infected women, menstruation and the prevalence of abnormal vaginal bleeding were not significantly different by CD4+ T-lymphocyte level. By multiple logistic regression analysis, neither HIV infection nor CD4+ T-lymphocyte level less than 200 cells/microL was associated with intermenstrual bleeding, postcoital bleeding, or no bleeding. CONCLUSION: The results of this study suggest that neither HIV infection nor immunosuppression has a clinically relevant effect on menstruation or other vaginal bleeding. Most HIV-infected women menstruate about every 25-35 days, suggesting monthly ovulation and an intact hypothalamic-pituitary-ovarian axis.

This article has been cited by other articles:

				H. E. Cejtin, A. Kalinowski, P. Bacchetti, R. N. Taylor, D. H. Watts, S. Kim, L. S. Massad, S. Preston-Martin, K. Anastos, M. Moxley, et al. Effects of Human Immunodeficiency Virus on Protracted Amenorrhea and Ovarian Dysfunction Obstet. Gynecol., December 1, 2006; 108(6): 1423 - 1431. [Abstract] [Full Text] [PDF]

				V. Martinet, Y. Manigart, S. Rozenberg, B. Becker, M. Gerard, and A. Delvigne Ovarian response to stimulation of HIV-positive patients during IVF treatment: a matched, controlled study Hum. Reprod., May 1, 2006; 21(5): 1212 - 1217. [Abstract] [Full Text] [PDF]

				P. Terriou, P. Auquier, V. Chabert-Orsini, J.M. Chinchole, L. Cravello, C. Giorgetti, P. Halfon, J. Salzmann, and R. Roulier Outcome of ICSI in HIV-1-infected women Hum. Reprod., October 1, 2005; 20(10): 2838 - 2843. [Abstract] [Full Text] [PDF]

				Y. Englert, B. Lesage, J.-P. Van Vooren, C. Liesnard, I. Place, A.-S. Vannin, S. Emiliani, and A. Delbaere Medically assisted reproduction in the presence of chronic viral diseases Hum. Reprod. Update, March 1, 2004; 10(2): 149 - 162. [Abstract] [Full Text] [PDF]

				J. C. Lo and M. Schambelan Reproductive Function in Human Immunodeficiency Virus Infection J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2338 - 2343. [Full Text] [PDF]

				S. L. Hader, D. K. Smith, J. S. Moore, and S. D. Holmberg HIV Infection in Women in the United States: Status at the Millennium JAMA, March 7, 2001; 285(9): 1186 - 1192. [Abstract] [Full Text] [PDF]

				I. Sinha-Hikim, S. Arver, G. Beall, R. Shen, M. Guerrero, F. Sattler, C. Shikuma, J. C. Nelson, B.-M. Landgren, N. A. Mazer, et al. The Use of a Sensitive Equilibrium Dialysis Method for the Measurement of Free Testosterone Levels in Healthy, Cycling Women and in Human Immunodeficiency Virus-Infected Women J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1312 - 1318. [Abstract] [Full Text]

				S. Grinspoon, C. Corcoran, K. Miller, B. M. K. Biller, H. Askari, E. Wang, J. Hubbard, E. J. Anderson, N. Basgoz, H. M. Heller, et al. Body Composition and Endocrine Function in Women with Acquired Immunodeficiency Syndrome Wasting J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1332 - 1337. [Abstract] [Full Text] [PDF]